Literature DB >> 16763513

Facts and fallacies concerning the prevention of contrast medium-induced nephropathy.

Michele Meschi1, Simona Detrenis, Sabrina Musini, Elena Strada, Giorgio Savazzi.   

Abstract

OBJECTIVE: The aim of this article is to extract from recent medical literature and nephrologic practice the facts and fallacies concerning the possible prophylaxis of contrast medium-induced nephropathy. DATA SOURCES, STUDY SELECTION, AND DATA EXTRACTION: A MEDLINE/PubMed search (1985 to January 2006) was conducted, including all relevant articles investigating the pathogenesis and prevention of contrast medium-induced nephropathy from a nephrologic critical point of view. DATA SYNTHESIS: Considerable efforts have been made to develop pharmacologic therapy for the prevention of contrast medium-induced nephropathy, especially in patients at risk, such as elderly subjects and those with preexisting renal impairment, hypovolemia, or dehydration. There is general consensus that hydration protocols implemented before and after imaging with contrast medium may be effective in preventing contrast medium-induced nephropathy. However, definitive and convincing data related to amounts to be infused, infusion timing, and type of solutions (half-isotonic, isotonic saline solution, or bicarbonate) are lacking. Forced diuresis with furosemide or mannitol and use of dopamine, together with concomitant hydration, have been proved to be ineffective or even more risky in the event of inadequate maintenance of euvolemia. Various direct or indirect vasodilators have been investigated (atrial natriuretic peptide, calcium channel blockers, angiotensin-converting enzyme inhibitors, and endothelin receptor antagonists), yet results have been inconsistent and inconclusive. Recent large meta-analyses concerning the protective role of antioxidant action of N-acetylcysteine have led to the conclusion that the statistical significance of the results is borderline. Preventive hemodialysis has not proved to be useful; on the contrary, it might worsen the clinical conditions by inducing hypotension. Hemofiltration, despite some positive studies, is too complex and cannot be used extensively.
CONCLUSIONS: : It is believed that prevention is actually achieved by correcting hypovolemia, dehydration, or both. Normalization of body fluids is probably the true objective to be achieved by preventive measures in all patients, not only in those at risk. Because limited data have been collected in intensive care units, at present, no firm or specific recommendations can yet be provided for the critically ill.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763513     DOI: 10.1097/01.CCM.0000227651.73500.BA

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  7 in total

1.  Oral prostaglandin e1 in combination with sodium bicarbonate and normal saline in the prevention of contrast-induced nephropathy: a pilot study.

Authors:  Randall W Franz; Scott S Hinze; Eric D Knapp; James J Jenkins
Journal:  Int J Angiol       Date:  2011-12

2.  Intensive care unit management of patients with stroke.

Authors:  Sebastian Schulz-Stübner
Journal:  Curr Treat Options Neurol       Date:  2007-11       Impact factor: 3.598

3.  Two-stage endovascular repair for concurrent penetrating atherosclerotic ulcers of the thoracic and abdominal aorta.

Authors:  Joon Hyuk Kong; Kang Seok Baek; Woo Hyung Kwun; Young Hwan Kim; Duk-Sil Kim; Sung-Wan Kim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-10-04

4.  Effects of iodinated contrast agents on renal oxygenation level determined by blood oxygenation level dependent magnetic resonance imaging in rabbit models of type 1 and type 2 diabetic nephropathy.

Authors:  Jia-huan Wang; Ke Ren; Wen-Ge Sun; Li Zhao; Hong-shan Zhong; Ke Xu
Journal:  BMC Nephrol       Date:  2014-09-02       Impact factor: 2.388

5.  Contrast-induced acute kidney injury: the importance of diagnostic criteria for establishing prevalence and prognosis in the intensive care unit.

Authors:  Edmilson Leal Bastos de Moura; Fábio Ferreira Amorim; William Huang; Marcelo de Oliveira Maia
Journal:  Rev Bras Ter Intensiva       Date:  2017-09-04

6.  Atorvastatin attenuates experimental contrast-induced acute kidney injury: a role for TLR4/MyD88 signaling pathway.

Authors:  Rongzheng Yue; Chuan Zuo; Jing Zeng; Baihai Su; Ye Tao; Songmin Huang; Rui Zeng
Journal:  Ren Fail       Date:  2017-11       Impact factor: 2.606

7.  DNA-free recombinant SV40 capsids protect mice from acute renal failure by inducing stress response, survival pathway and apoptotic arrest.

Authors:  Veronika Butin-Israeli; Dotan Uzi; Mahmoud Abd-El-Latif; Galina Pizov; Arieh Eden; Yosef S Haviv; Ariella Oppenheim
Journal:  PLoS One       Date:  2008-08-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.